
Akkermansia-powered metabolic microbiome support.
A next-generation probiotic formula designed to support digestive balance, metabolic pathways and gut-barrier resilience.
Pricing & subscription announced at launch · 30 capsules · vegetarian
Supports glucose and lipid metabolism pathways.
Helps maintain the intestinal barrier environment.
For people focused on body composition, cravings and metabolic health.
Named strains, chosen for their role — not a mystery powder.
The hero strain — associated with the gut’s mucin layer and metabolic signalling.
Studied for digestive support and colonisation.
Used in gut-microbiota modulation contexts.
Butyrate-related gut-ecology positioning.
The exact final formula is confirmed on the label at production. Strain list shown reflects the intended metabolic blend.
Akkermansia is associated with the protective mucin layer of the gut lining.
Supports a healthy gut environment and barrier function.
Research links Akkermansia mechanisms with glucose and lipid metabolism pathways, including GLP-1 signalling.
Gut, metabolism, energy and inflammation balance — working as one system.
A randomized, double-blind, placebo-controlled exploratory study in overweight and obese insulin-resistant volunteers evaluated oral supplementation with A. muciniphila for three months. The intervention was reported as safe and well tolerated. Pasteurized A. muciniphila showed improvements in insulin sensitivity, insulinemia and total cholesterol versus placebo, with modest changes in body weight and fat mass.
| Study type | Randomized, double-blind, placebo-controlled pilot |
| Participants | 40 enrolled · 32 completed |
| Duration | 3 months |
| Dose | 1010 bacteria per day |
| Tolerability | Safe and well tolerated |
| Metabolic observations | Insulin sensitivity · insulinemia · total cholesterol · body-weight / fat-mass trends |
Exact directions are confirmed on the final label specification.